• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高敏C反应蛋白升高的不稳定型心绞痛患者外周血单核细胞中训练免疫增强

Enhanced Trained Immunity in Peripheral Monocytes in Unstable Angina With Elevated High-Sensitivity C-Reactive Protein.

作者信息

Zhang Jiyu, Yang Fen, Liao Yuhan, Xia Xinyi, Yu Miao, Hu Desheng, Wang Weimin, Zhang Li, Wang Chaolong, Liu Huirong, Chen Chen, Wang Qing K, Shan Zhilei, Libby Peter, Cheng Xiang

机构信息

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Engineering Research Center for Immunological Diagnosis and Therapy of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Biological Targeted Therapy, Huazhong University of Science and Technology, Ministry of Education, Wuhan, China.

Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

JACC Basic Transl Sci. 2025 Jun 24;10(7):101300. doi: 10.1016/j.jacbts.2025.04.014.

DOI:10.1016/j.jacbts.2025.04.014
PMID:40561640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12256326/
Abstract

Despite effective secondary prevention for coronary heart diseases, recurrent events remain high. Elevated high-sensitivity C-reactive protein (hsCRP) indicates increased inflammation risk. This study aimed to investigate the trained immunity of circulating monocytes in unstable angina (UA) patients with elevated hsCRP. We analyzed CD14 monocytes from UA patients, comparing high-risk (hsCRP ≥3 mg/L) and low-risk (hsCRP <1 mg/L) groups. We assessed cytokine production and conducted metabolic, transcriptional, and epigenetic profiling. Patients with elevated hsCRP exhibited enhanced proinflammatory responses, glycolytic activity, and altered immune profiles, indicating sustained monocyte trained immunity, which contributes to residual inflammation risk in cardiovascular disease.

摘要

尽管针对冠心病有有效的二级预防措施,但复发事件的发生率仍然很高。高敏C反应蛋白(hsCRP)升高表明炎症风险增加。本研究旨在调查hsCRP升高的不稳定型心绞痛(UA)患者循环单核细胞的训练免疫情况。我们分析了UA患者的CD14单核细胞,比较了高危组(hsCRP≥3mg/L)和低危组(hsCRP<1mg/L)。我们评估了细胞因子的产生,并进行了代谢、转录和表观遗传分析。hsCRP升高的患者表现出增强的促炎反应、糖酵解活性和改变的免疫谱,表明单核细胞训练免疫持续存在,这导致了心血管疾病中的残余炎症风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/5fde50489f34/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/d74fcb4f5aed/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/0f9099829b9c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/c858aad46fd2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/621406205a80/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/cabbad89fed8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/8ad13990f2c7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/fdf02b75ac50/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/b524175a2ed7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/044bc0e9df4c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/5fde50489f34/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/d74fcb4f5aed/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/0f9099829b9c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/c858aad46fd2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/621406205a80/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/cabbad89fed8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/8ad13990f2c7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/fdf02b75ac50/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/b524175a2ed7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/044bc0e9df4c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ec/12256326/5fde50489f34/gr9.jpg

相似文献

1
Enhanced Trained Immunity in Peripheral Monocytes in Unstable Angina With Elevated High-Sensitivity C-Reactive Protein.高敏C反应蛋白升高的不稳定型心绞痛患者外周血单核细胞中训练免疫增强
JACC Basic Transl Sci. 2025 Jun 24;10(7):101300. doi: 10.1016/j.jacbts.2025.04.014.
2
Association of Decreased Fecal Microbiota Akkermansia with Increased High-Sensitivity C-Reactive Protein Levels in Patients with Unstable Angina.粪便微生物群中阿克曼氏菌减少与不稳定型心绞痛患者高敏C反应蛋白水平升高的关联。
Curr Med Sci. 2025 Apr 24. doi: 10.1007/s11596-025-00050-2.
3
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologists.关于高敏C反应蛋白检测(hsCRP)在动脉粥样硬化性心血管疾病中的认知:一项针对美国心脏病专家和肾病专家的调查
Future Cardiol. 2025 Jul;21(9):701-710. doi: 10.1080/14796678.2025.2514349. Epub 2025 Jun 3.
4
Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.支架时代不稳定型心绞痛和非ST段抬高型心肌梗死的常规侵入性策略与选择性侵入性策略
Cochrane Database Syst Rev. 2016 May 26;2016(5):CD004815. doi: 10.1002/14651858.CD004815.pub4.
5
Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI.接受经皮冠状动脉介入治疗(PCI)患者中,根据多血管动脉粥样硬化疾病状态评估的炎症风险和临床结局
Clin Res Cardiol. 2024 Jun 20. doi: 10.1007/s00392-024-02471-w.
6
Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial.非ST段抬高型心肌梗死后高敏C反应蛋白与高危易损斑块的关系:来自PROSPECT II试验的见解
JACC Cardiovasc Interv. 2025 May 26;18(10):1217-1228. doi: 10.1016/j.jcin.2025.01.440. Epub 2025 Apr 23.
7
Efficacy and safety of Shuxuening injection in patients with unstable angina: a multicenter, randomized, placebo-controlled trial.舒血宁注射液治疗不稳定型心绞痛患者的疗效与安全性:一项多中心、随机、安慰剂对照试验
Phytomedicine. 2025 Aug;144:156916. doi: 10.1016/j.phymed.2025.156916. Epub 2025 May 27.
8
Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases.白介素受体拮抗剂和肿瘤坏死因子抑制剂用于动脉粥样硬化性心血管疾病的一级和二级预防。
Cochrane Database Syst Rev. 2024 Sep 19;9(9):CD014741. doi: 10.1002/14651858.CD014741.pub2.
9
High-sensitivity c-reactive protein and cardiovascular disease risk assessment in a population of type 2 diabetes mellitus patients.2型糖尿病患者群体中高敏C反应蛋白与心血管疾病风险评估
BMC Cardiovasc Disord. 2025 Jul 9;25(1):498. doi: 10.1186/s12872-025-04975-3.
10
Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges.循环单核细胞上调CD52并维持肝硬化患者的固有免疫功能,除非出现急性失代偿。
J Hepatol. 2025 Jul;83(1):146-160. doi: 10.1016/j.jhep.2024.12.031. Epub 2025 Jan 14.

本文引用的文献

1
Residual Inflammatory Risk in Outcomes of Chinese Patients After Percutaneous Coronary Intervention.中国患者经皮冠状动脉介入治疗后结局中的残余炎症风险
JACC Asia. 2024 Jul 23;4(8):636-638. doi: 10.1016/j.jacasi.2024.05.004. eCollection 2024 Aug.
2
Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.心肌梗死驱动单核细胞的训练免疫,加速动脉粥样硬化。
Eur Heart J. 2024 Mar 1;45(9):669-684. doi: 10.1093/eurheartj/ehad787.
3
Summary of the 2022 Report on Cardiovascular Health and Diseases in China.
《中国心血管健康与疾病报告 2022》概要。
Chin Med J (Engl). 2023 Dec 20;136(24):2899-2908. doi: 10.1097/CM9.0000000000002927. Epub 2023 Nov 25.
4
Trained immunity in atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病中的训练免疫。
Nat Rev Cardiol. 2023 Dec;20(12):799-811. doi: 10.1038/s41569-023-00894-y. Epub 2023 Jun 15.
5
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. inflammasome 的全景:激活机制、细胞死亡与疾病。
Cell. 2023 May 25;186(11):2288-2312. doi: 10.1016/j.cell.2023.04.025.
6
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.炎症和胆固醇作为接受他汀类药物治疗患者心血管事件的预测因素:三项随机试验的联合分析
Lancet. 2023 Apr 15;401(10384):1293-1301. doi: 10.1016/S0140-6736(23)00215-5. Epub 2023 Mar 6.
7
Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.东亚患者冠状动脉介入治疗后的残余炎症风险及其与事件的关联。
JACC Asia. 2022 Apr 12;2(3):323-337. doi: 10.1016/j.jacasi.2021.11.014. eCollection 2022 Jun.
8
The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.Fra-1:在调节广泛的免疫细胞状态和影响炎症性疾病中的新作用。
Front Immunol. 2022 Aug 11;13:954744. doi: 10.3389/fimmu.2022.954744. eCollection 2022.
9
Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling.ST 段抬高型心肌梗死后的心力衰竭:超越左心室不良重构。
Curr Probl Cardiol. 2023 Aug;48(8):101215. doi: 10.1016/j.cpcardiol.2022.101215. Epub 2022 Apr 20.
10
Impact of cholesterol on proinflammatory monocyte production by the bone marrow.胆固醇对骨髓前炎性单核细胞生成的影响。
Eur Heart J. 2021 Nov 7;42(42):4309-4320. doi: 10.1093/eurheartj/ehab465.